Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at risk.

  • Authors : Cheng K; Changhai Hospital, Second Military Medical University, Shanghai, China.; Shi J

Subjects: Biomarkers, Tumor* ; Blood Proteins*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*diagnosis

  • Source: EBioMedicine [EBioMedicine] 2020 Feb; Vol. 52, pp. 102638. Date of Electronic Publication: 2020 Jan 31.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Pathway-based biomarker identification with crosstalk analysis for robust prognosis prediction in hepatocellular carcinoma.

  • Authors : Fa B; Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China; SJTU-Yale Joint Centre for Biostatistics, Shanghai Jiao Tong University, Shanghai, China.

Subjects: Biomarkers, Tumor* ; Signal Transduction*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism

  • Source: EBioMedicine [EBioMedicine] 2019 Jun; Vol. 44, pp. 250-260. Date of Electronic Publication: 2019 May 14.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Comprehensive molecular and immunological characterization of hepatocellular carcinoma.

  • Authors : Shimada S; Department of Molecular Oncology Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.; Mogushi K

Subjects: Biomarkers, Tumor* ; Immunomodulation*/Immunomodulation*/Immunomodulation*/genetics; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics

  • Source: EBioMedicine [EBioMedicine] 2019 Feb; Vol. 40, pp. 457-470. Date of Electronic Publication: 2018 Dec 29.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma.

  • Authors : Peng H; Department of General Surgery, The First Affiliated Hospital, Sun Yat- sen University, Guangzhou 510080, PR China.; Zhang Y

Subjects: Mutation*; Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics

  • Source: EBioMedicine [EBioMedicine] 2019 Aug; Vol. 46, pp. 105-118. Date of Electronic Publication: 2019 Jul 16.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Plasma HSP90α and liver cancer: a potential biomarker?

  • Authors : Sourbier C; Urologic Oncology Branch, National Cancer Institute, NIH, Bldg 10, CRC 1W-3961, 9000 Rockville Pike, Bethesda, MD 20892, United States. Electronic address: .

Subjects: Biomarkers, Tumor* ; Liver Neoplasms*; HSP90 Heat-Shock Proteins

  • Source: EBioMedicine [EBioMedicine] 2017 Nov; Vol. 25, pp. 7-8. Date of Electronic Publication: 2017 Oct 10.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.

  • Authors : Meng F; Department of General Surgery, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.; Zhang S

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism ; Chromosomal Proteins, Non-Histone/Chromosomal Proteins, Non-Histone/Chromosomal Proteins, Non-Histone/*genetics

  • Source: EBioMedicine [EBioMedicine] 2019 Jun; Vol. 44, pp. 237-249. Date of Electronic Publication: 2019 Jun 05.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5.

  • Authors : Weng X; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China; Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, China.

Subjects: Signal Transduction*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism

  • Source: EBioMedicine [EBioMedicine] 2019 Jun; Vol. 44, pp. 225-236. Date of Electronic Publication: 2019 May 17.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.

  • Authors : Liao H; Department of Liver Surgery, Liver Transplantation Division, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.; Liao M

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*pathology ; Carrier Proteins/Carrier Proteins/Carrier Proteins/*metabolism ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*pathology

  • Source: EBioMedicine [EBioMedicine] 2019 Mar; Vol. 41, pp. 310-319. Date of Electronic Publication: 2019 Jan 18.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.

  • Authors : Cai J; Translational Medicine Research Center, Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Shanghai 201821, PR China.; Li B

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; CDC2 Protein Kinase/CDC2 Protein Kinase/CDC2 Protein Kinase/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics

  • Source: EBioMedicine [EBioMedicine] 2017 May; Vol. 19, pp. 18-30. Date of Electronic Publication: 2017 Apr 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma.

  • Authors : Long J; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Wang A

Subjects: Immunomodulation* ; Models, Biological*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*etiology

  • Source: EBioMedicine [EBioMedicine] 2019 Apr; Vol. 42, pp. 363-374. Date of Electronic Publication: 2019 Mar 16.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  20 results for ""Biomarkers, Tumor""